Source-grounded facts extracted from RetinalGenix Technologies Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Dessislava Boneva was appointed as director at RetinalGenix Technologies Inc..
“On December 4, 2023, the Board of Directors (the “Board”) of RetinalGenix Technologies Inc. (the ‘Company”) appointed Ms. Dessislava (Dessy) Boneva M.D. FACS, to serve as a director of the Company.”
Virender Ahluwalia was appointed as Interim Chief Financial Officer at RetinalGenix Technologies Inc..
“On November 30, 2023, the Board of Directors (the “Board”) of RetinalGenix Technologies Inc. (the ‘Company”) appointed Virender Ahluwalia to serve as Interim Chief Financial Officer of the Company.”
Vinay Mehindru was appointed as director at RetinalGenix Technologies Inc..
“On July 25, 2022, the Board of Directors (the “Board”) of RetinalGenix Inc. (the ‘Company”) appointed Vinay Mehindru, MD, MBA to serve as a director of the Company.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.